IPEX (syndrome)
IPEX (syndrome) | |
OMIM | 304790 |
---|---|
DiseasesDB | 33417 |
WikiDoc Resources for IPEX (syndrome) |
Articles |
---|
Most recent articles on IPEX (syndrome) Most cited articles on IPEX (syndrome) |
Media |
Powerpoint slides on IPEX (syndrome) |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on IPEX (syndrome) at Clinical Trials.gov Trial results on IPEX (syndrome) Clinical Trials on IPEX (syndrome) at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on IPEX (syndrome) NICE Guidance on IPEX (syndrome)
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on IPEX (syndrome) Discussion groups on IPEX (syndrome) Patient Handouts on IPEX (syndrome) Directions to Hospitals Treating IPEX (syndrome) Risk calculators and risk factors for IPEX (syndrome)
|
Healthcare Provider Resources |
Causes & Risk Factors for IPEX (syndrome) |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
IPEX stands for immunodysregulation polyendocrinopathy enteropathy X-linked syndrome and it is a rare disease linked to the dysfunction of the transcriptional activator FoxP3. [1]
It leads to the dysfunction of regulatory T-cells and the subsequent autoimmunity.
This autoimmunity is called IPEX and it is the attack from the body's own immune system against the body's own tissues and organs. Early age onset of this disease in males causes severe enlargement of the secondary lymphoid organs, insulin dependent diabetes, eczema, food allergies, and infections. There has been limited success in treating the syndrome by bone marrow transplantation.[2]
References
- ↑ Yong PL, Russo P, Sullivan KE (2008). "Use of Sirolimus in IPEX and IPEX-Like Children". J. Clin. Immunol. doi:10.1007/s10875-008-9196-1. PMID 18481161. Unknown parameter
|month=
ignored (help) - ↑ Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome